Top News

Apr 12, 2018
By BioPharm International Editors
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
Apr 09, 2018
By BioPharm International Editors
The acquisition is expected to accelerate progress towards personalized cancer healthcare.
Apr 06, 2018
By BioPharm International Editors
Boehringer Ingelheim and OSE Immunotherapeutics have entered a global immuno-oncology partnership to develop a checkpoint inhibitor for treating advanced solid tumors.
Apr 05, 2018
By BioPharm International Editors
Fujifilm acquires cell culture media companies Irvine Scientific Sales Company and IS Japan.
Mar 28, 2018
By BioPharm International Editors
Takeda is considering approaching Shire with a possible offer.
Mar 27, 2018
By BioPharm International Editors
In a $13-billion transaction, GSK will purchase Novartis’ share of the Consumer Healthcare Joint Venture.
Mar 19, 2018
By BioPharm International Editors
The companies intend to jointly develop and commercialize Lenvima (lenvatinib mesylate) as a monotherapy and an in-combination therapy for treating multiple cancer types.
Mar 13, 2018
By BioPharm International Editors
The $11.6-billion acquisition strengthens Sanofi's position in hematology and specialty medicines.
Mar 06, 2018
By BioPharm International Editors
The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.
Feb 27, 2018
By BioPharm International Editors
Roche will acquire oncology-focused healthcare technology and services company Flatiron Health for $1.9 billion to further its personalized oncological healthcare strategy.
native1_300x100
lorem ipsum